Nele Van Der Steen Center for Oncological Research (CORE) Antwerp University Biography Publications Institution JoVE Articles Nele Van Der Steen has not added a biography. If you are Nele Van Der Steen and would like to personalize this page please email our Author Liaison for assistance. Publications APR-246 (PRIMA-1(MET)) Strongly Synergizes with AZD2281 (olaparib) Induced PARP Inhibition to Induce Apoptosis in Non-small Cell Lung Cancer Cell Lines Cancer Letters. Jun, 2016 | Pubmed ID: 26975633 Onartuzumab in Lung Cancer: the Fall of Icarus? Expert Review of Anticancer Therapy. May, 2015 | Pubmed ID: 25818471 CMET in NSCLC: Can We Cut off the Head of the Hydra? From the Pathway to the Resistance Cancers. 2015 | Pubmed ID: 25815459 The Role of CMet in Non-small Cell Lung Cancer Resistant to EGFR-inhibitors: Did We Really Find the Target? Current Drug Targets. 2014 | Pubmed ID: 25511614 Exosomal miRNA Analysis in Non-small Cell Lung Cancer (NSCLC) Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool Marco Giallombardo*1,2, Jorge Chacártegui Borrás*2,3, Marta Castiglia4, Nele Van Der Steen3, Inge Mertens5,6, Patrick Pauwels7,3, Marc Peeters8,3, Christian Rolfo2,3 1Department of Biopathology and Medical Biotechnology, Section of Biology and Genetics, University of Palermo, 2Phase I-Early Clinical Trials Unit, Oncology Department, Antwerp University Hospital (UZA), 3Center for Oncological Research (CORE), Antwerp University, 4Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, 5Flemish Institute for Technological Research (VITO), 6CORE, Campus Groenenborger, Antwerp University, 7Molecular Pathology, Pathology Department, Antwerp University Hospital (UZA), 8Oncology Department, Antwerp University Hospital (UZA) JoVE 53900 Medicina
Exosomal miRNA Analysis in Non-small Cell Lung Cancer (NSCLC) Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool Marco Giallombardo*1,2, Jorge Chacártegui Borrás*2,3, Marta Castiglia4, Nele Van Der Steen3, Inge Mertens5,6, Patrick Pauwels7,3, Marc Peeters8,3, Christian Rolfo2,3 1Department of Biopathology and Medical Biotechnology, Section of Biology and Genetics, University of Palermo, 2Phase I-Early Clinical Trials Unit, Oncology Department, Antwerp University Hospital (UZA), 3Center for Oncological Research (CORE), Antwerp University, 4Department of Surgical, Oncological and Oral Sciences, Section of Medical Oncology, University of Palermo, 5Flemish Institute for Technological Research (VITO), 6CORE, Campus Groenenborger, Antwerp University, 7Molecular Pathology, Pathology Department, Antwerp University Hospital (UZA), 8Oncology Department, Antwerp University Hospital (UZA) JoVE 53900 Medicina